BR112013031813A2 - composição para aplicação tópica - Google Patents
composição para aplicação tópicaInfo
- Publication number
- BR112013031813A2 BR112013031813A2 BR112013031813A BR112013031813A BR112013031813A2 BR 112013031813 A2 BR112013031813 A2 BR 112013031813A2 BR 112013031813 A BR112013031813 A BR 112013031813A BR 112013031813 A BR112013031813 A BR 112013031813A BR 112013031813 A2 BR112013031813 A2 BR 112013031813A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- topical application
- topical
- application
- Prior art date
Links
- 230000000699 topical effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161502725P | 2011-06-29 | 2011-06-29 | |
| PCT/IL2012/050223 WO2013001536A1 (en) | 2011-06-29 | 2012-06-28 | Stabilized topical formulations containing core-shell microcapsules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013031813A2 true BR112013031813A2 (pt) | 2016-12-13 |
Family
ID=47423504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013031813A BR112013031813A2 (pt) | 2011-06-29 | 2012-06-28 | composição para aplicação tópica |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20130095185A1 (pt) |
| EP (2) | EP3698778B1 (pt) |
| JP (1) | JP6033859B2 (pt) |
| KR (1) | KR20140043397A (pt) |
| CN (2) | CN103732217A (pt) |
| AU (1) | AU2012277322A1 (pt) |
| BR (1) | BR112013031813A2 (pt) |
| CA (1) | CA2834681C (pt) |
| EA (1) | EA201490178A1 (pt) |
| ES (2) | ES2786103T3 (pt) |
| IL (1) | IL229083A0 (pt) |
| MX (1) | MX363379B (pt) |
| WO (1) | WO2013001536A1 (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5164840B2 (ja) | 2005-08-02 | 2013-03-21 | ソル − ゲル テクノロジーズ リミテッド | 水不溶性成分の金属酸化物被覆 |
| KR20110084151A (ko) | 2008-07-31 | 2011-07-21 | 솔-겔 테크놀로지스 리미티드 | 활성성분을 포함하는 마이크로캡슐 및 금속 산화물 쉘, 그의 제조방법 및 그의 용도 |
| US11071878B2 (en) | 2009-12-31 | 2021-07-27 | Sol-Gel Technologies Ltd. | Core stabilized microcapsules, method of their preparation and uses thereof |
| ES2786103T3 (es) | 2011-06-29 | 2020-10-08 | Sol Gel Tech Ltd | Formulaciones tópicas estabilizadas que contienen microcápsulas de núcleo-cubierta |
| US9687465B2 (en) * | 2012-11-27 | 2017-06-27 | Sol-Gel Technologies Ltd. | Compositions for the treatment of rosacea |
| EP3078415B1 (en) * | 2013-12-06 | 2019-11-06 | Kao Corporation | Method for manufacturing microcapsules |
| WO2015092602A1 (en) * | 2013-12-17 | 2015-06-25 | Ranbaxy Laboratories Limited | Topical pharmaceutical composition of a retinoid |
| GB201411704D0 (en) * | 2014-07-01 | 2014-08-13 | Lucideon Ltd | Coated particles |
| EP3337472A4 (en) * | 2015-08-20 | 2019-05-15 | Sol-Gel Technologies Ltd. | COMPOSITIONS FOR TOPICAL USE WITH BENZOYL PEROXIDE AND ADAPALS |
| AU2017229125B2 (en) | 2016-03-08 | 2021-07-29 | Living Proof, Inc. | Long lasting cosmetic compositions |
| CN107260586B (zh) * | 2017-06-27 | 2020-08-04 | 国珍健康科技（北京）有限公司 | 一种卸妆乳凝胶及其制备方法 |
| EP3651755A4 (en) | 2017-07-12 | 2021-03-24 | Sol-Gel Technologies Ltd. | METHODS AND COMPOSITIONS FOR TREATMENT OF ACNE |
| JP2020527140A (ja) * | 2017-07-12 | 2020-09-03 | ソル − ゲル テクノロジーズ リミテッド | カプセル化トレチノインを含む組成物 |
| WO2019055440A1 (en) | 2017-09-13 | 2019-03-21 | Living Proof, Inc. | LONG-TERM COSMETIC COMPOSITIONS |
| JP7244494B2 (ja) | 2017-09-13 | 2023-03-22 | リビング プルーフ インコーポレイテッド | 色保護剤組成物 |
| US11364198B2 (en) | 2018-04-05 | 2022-06-21 | Bausch Health Ireland Limited | Polymeric emulsion delivery systems |
| WO2020170031A2 (en) | 2019-02-19 | 2020-08-27 | Sol-Gel Technologies Ltd. | Method for treatment of rosacea |
| KR20230027073A (ko) * | 2020-05-22 | 2023-02-27 | 솔-겔 테크놀로지스 리미티드 | 안정화된 마이크로캡슐, 그의 제조 방법 및 그의 용도 |
| KR102220752B1 (ko) * | 2020-08-13 | 2021-03-02 | 한국콜마주식회사 | 캡슐을 함유하는 화장료 조성물 |
| CN116919939A (zh) * | 2022-04-02 | 2023-10-24 | 南京毓浠医药技术有限公司 | 一种维a酸和过氧化苯甲酰组合物及其制备方法和用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3906108A (en) * | 1973-10-12 | 1975-09-16 | Johnson & Johnson | Stabilized tretinoin cream emulsion |
| JP3050601B2 (ja) * | 1993-02-26 | 2000-06-12 | エスティー ローダー インコーポレーテッド | 二酸化チタン分散液、化粧品組成物およびそれを使用する方法 |
| US5401517A (en) * | 1993-11-15 | 1995-03-28 | Elizabeth Arden Company, Division Of Conopco, Inc. | Cosmetic method for treatment of skin |
| US5720949A (en) * | 1996-05-06 | 1998-02-24 | Bristol-Myers Squibb Company | Foamable cosmetic mask product |
| US6238650B1 (en) * | 1999-05-26 | 2001-05-29 | Sol-Gel Technologies Ltd. | Sunscreen composition containing sol-gel microcapsules |
| US7758888B2 (en) * | 2000-04-21 | 2010-07-20 | Sol-Gel Technologies Ltd. | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
| DE10117842A1 (de) * | 2001-04-04 | 2002-10-17 | Coty Bv | Kosmetische Vitamin-A-haltige Zubereitung |
| US20030082217A1 (en) * | 2001-10-25 | 2003-05-01 | Isabelle Afriat | Use of heat-stabilizing microcapsules to improve the activity or penetration of cosmetic or pharmaceutical active principles |
| US7923030B2 (en) * | 2003-03-14 | 2011-04-12 | Sol-Gel Technologies, Inc. | Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same |
| WO2007092312A2 (en) * | 2006-02-03 | 2007-08-16 | Stiefel Laboratories, Inc. | Topical skin treating compositions |
| MX2009008250A (es) * | 2007-02-01 | 2009-08-27 | Sol Gel Technologies Ltd | Composiciones para aplicacion topica que comprenden un peroxido y retinoide. |
| US20090130220A1 (en) * | 2007-11-20 | 2009-05-21 | Johnson Pamela A | Cosmetic composition having pomace olive oil |
| WO2009077693A2 (fr) * | 2007-11-30 | 2009-06-25 | Galderma Research & Development | Compositions comprenant au moins un derive de l'acide naphtoïque, du peroxyde de benzoyle et au moins un agent filmogene, leurs procedes de preparation, et leurs utilisations |
| KR20110084151A (ko) * | 2008-07-31 | 2011-07-21 | 솔-겔 테크놀로지스 리미티드 | 활성성분을 포함하는 마이크로캡슐 및 금속 산화물 쉘, 그의 제조방법 및 그의 용도 |
| MX344128B (es) | 2009-12-31 | 2016-12-06 | Sol-Gel Tech Ltd * | Microcapsulas estabilizadas con nucleo, metodo para su preparacion y usos de las mismas. |
| ES2786103T3 (es) | 2011-06-29 | 2020-10-08 | Sol Gel Tech Ltd | Formulaciones tópicas estabilizadas que contienen microcápsulas de núcleo-cubierta |
-
2012
- 2012-06-28 ES ES12804460T patent/ES2786103T3/es active Active
- 2012-06-28 ES ES20156654T patent/ES2902498T3/es active Active
- 2012-06-28 WO PCT/IL2012/050223 patent/WO2013001536A1/en active Application Filing
- 2012-06-28 KR KR1020137033712A patent/KR20140043397A/ko not_active Application Discontinuation
- 2012-06-28 CA CA2834681A patent/CA2834681C/en active Active
- 2012-06-28 EP EP20156654.4A patent/EP3698778B1/en active Active
- 2012-06-28 JP JP2014518066A patent/JP6033859B2/ja active Active
- 2012-06-28 MX MX2013013722A patent/MX363379B/es unknown
- 2012-06-28 EP EP12804460.9A patent/EP2726067B1/en active Active
- 2012-06-28 CN CN201280024937.1A patent/CN103732217A/zh active Pending
- 2012-06-28 BR BR112013031813A patent/BR112013031813A2/pt not_active IP Right Cessation
- 2012-06-28 CN CN201710888180.5A patent/CN107625743B/zh active Active
- 2012-06-28 AU AU2012277322A patent/AU2012277322A1/en not_active Abandoned
- 2012-06-28 EA EA201490178A patent/EA201490178A1/ru unknown
- 2012-06-29 US US13/537,646 patent/US20130095185A1/en active Pending
-
2013
- 2013-10-27 IL IL229083A patent/IL229083A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6033859B2 (ja) | 2016-11-30 |
| JP2014518259A (ja) | 2014-07-28 |
| ES2902498T3 (es) | 2022-03-28 |
| EP2726067A1 (en) | 2014-05-07 |
| IL229083A0 (en) | 2013-12-31 |
| AU2012277322A1 (en) | 2013-11-14 |
| MX363379B (es) | 2019-03-21 |
| MX2013013722A (es) | 2014-02-27 |
| ES2786103T3 (es) | 2020-10-08 |
| CN107625743B (zh) | 2021-08-27 |
| US20130095185A1 (en) | 2013-04-18 |
| EP2726067A4 (en) | 2014-12-24 |
| WO2013001536A1 (en) | 2013-01-03 |
| EP3698778B1 (en) | 2021-10-13 |
| CN103732217A (zh) | 2014-04-16 |
| EP3698778A1 (en) | 2020-08-26 |
| EP2726067B1 (en) | 2020-02-19 |
| CN107625743A (zh) | 2018-01-26 |
| CA2834681A1 (en) | 2013-01-03 |
| CA2834681C (en) | 2019-03-12 |
| EA201490178A1 (ru) | 2014-04-30 |
| KR20140043397A (ko) | 2014-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013031813A2 (pt) | composição para aplicação tópica | |
| SMT201600308B (it) | Composti di benzene arile-o eteroarile-sostituiti | |
| CR20130677A (es) | FORMULACIÓN PARA ANTICUERPO ANTI-a4ß7 | |
| BR112013022112A2 (pt) | composição | |
| BR112013022102A2 (pt) | composição | |
| DK2686017T3 (da) | Oftalmisk sammensætning | |
| BR112014004395A2 (pt) | composição | |
| CO6801648A2 (es) | Formulación para anticuerpo anti-α4β7 | |
| DK2694038T3 (da) | Farmaceutisk sammensætning | |
| BRDI7106210S (pt) | Configuração aplicada para lâmina para microscópio | |
| BR302012002270S1 (pt) | Configuracao aplicada em motoneta | |
| DK2730310T3 (da) | Applikator | |
| BR112013033808A2 (pt) | composição | |
| BR112014013682A2 (pt) | composição para cuidado pessoal | |
| BR112014009963A2 (pt) | composição dietética | |
| PT2694021E (pt) | Composição cicatrizante para aplicação tópica | |
| BR112014007030A2 (pt) | composição | |
| BR112014032712A2 (pt) | composição | |
| BR112013031544A2 (pt) | composição tópica. | |
| BR112014011723A2 (pt) | composição antiperspirante | |
| BR112013031220A2 (pt) | composição tópica | |
| BR112014013684A2 (pt) | composição para cuidado pessoal | |
| BR112013022907A2 (pt) | composição farmacêutica | |
| SMT201600068B (it) | Composizione dolcificante | |
| DK2726579T3 (da) | Sammensætning |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |